Guidance
Update information
September 2023: We have reviewed the evidence and updated or made new recommendations on detecting and preventing bleeding from medium or large oesophageal varices, and on preventing spontaneous bacterial peritonitis (SBP). We also added new recommendations on the safe prescribing and use of carvedilol and propranolol in people with cirrhosis, and the use of these non-selective beta-blockers for the primary prevention of decompensation. These recommendations are marked [2023].
We have also changed recommendations 1.2.7 and 1.2.8 without an evidence review. These changes have been made to clarify that people with cirrhosis who are planning to take carvedilol or propranolol to prevent decompensation do not need an upper gastrointestinal endoscopy. The recommendations are marked [2016, amended 2023].
Recommendations marked [2016] last had an evidence review in 2016. In some cases, minor changes have been made to the wording to bring the language and style up to date, without changing the meaning.
ISBN: 978-1-4731-5348-6